Home
The Infectious Diseases Clinical Research Consortium (IDCRC) and Vaccine and Treatment Evaluation Units (VTEUs) work in tandem with the National Institute of Allergy and Infectious Diseases (NIAID) as a coordinated national and global network of scientific experts working to develop and test vaccines and other therapies to combat infectious diseases.
About
The IDCRC works through a flexible, sustaining structure to advance new countermeasures and approaches to product development, implement efficient clinical study/trial designs, and support exceptional career development and mentoring of future leaders in infectious diseases clinical research. The consortium's collective experience and access to diverse populations give it the ability to evaluate new vaccines and therapies for infectious diseases.
Jim Campbell, MD, MS, named IDCRC Leadership Group (LG) Vice-Chair
The IDCRC Leadership Group (LG) is pleased to announce that James (Jim) Campbell, MD, MS, has accepted the position of Leadership Group (LG) vice-chair, effective May 2024. This appointment comes as Kathleen Neuzil, MD, MPH, FIDSA, recently stepped down as LG co-chair to become the director of the Fogarty International Center and NIH associate director for international research.
VIEW FULL ANNOUNCEMENTCOVID-19 Prevention Network
The CoVPN was established by merging four existing NIAID-funded clinical trials networks: the HIV Vaccine Trials Network; the HIV Prevention Trials Network; the Infectious Diseases Clinical Research Consortium; and the AIDS Clinical Trials Group.
More about the CoVPNNews from VTEU Trials
IDCRC Leadership Group
IDCRC Concept Quick Stats
ICP Status
- Approved: 56
- Administratively Not Supported: 29
- Not Approved: 52
- EWG Review: 1
- EWG Liaisons: 0
- EMT Concurrence: 2
- Withdrawn: 15
- Hold: 1
- Moved to Active Study: 2
EWG Assignment
- COVID: 92
- Respiratory: 27
- Emerging Infections: 14
- Enteric Infections: 7
- Malaria/Topical Diseases: 13
- STI: 17
ECP
- EWG Review-In Process: 4
- EMT Review: 2
- Approved-moved to Prioritization: 4
- Not Approved: 17
- Approved-moved to Protocol Development: 1
- Active Study: 5
- EMT Vote: 0
- Study in Protocol Development: 7
- Study Closed (LSLV Complete): 6
- Other: 8
IDCRC Citation Statement
Please include the following citation in any publications resulting from direct or indirect IDCRC support:
"Supported by the Infectious Diseases Clinical Research Consortium through the National Institute for Allergy and Infectious Diseases of the National Institutes of Health, under award number UM1AI148684. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health."